Millennium CEO
Executive Summary
Novartis North American oncology operations head Deborah Dunsire will succeed Mark Levin as CEO of Millennium by Aug. 1. Levin, a Millennium co-founder, will become a member of the board. Dunsire has headed Novartis' North American oncology operations since 1997; over the last eight years, the U.S. business achieved a compounded annual growth rate of 25%. Dunsire plans to take a "fresh look" at the Millennium business and will develop a strategy aimed at helping the company meet its goal of non-GAAP profitability by 2006...